RESEARCH INST OF FOX CHASE CAN CTR
Small-molecule exploitation of ZBP1-driven nuclear necroptosis for cancer immunotherapy
Small-molecule exploitation of ZBP1-driven nuclear necroptosis for cancer immunotherapy is a funding opportunity from RESEARCH INST OF FOX CHASE CAN CTR, up to 758985, closing December 31, 2027.
Dec 31, 2027
(518d left)Overview
PROJECT SUMMARY/ABSTRACT. Immune checkpoint blockade (ICB) and other immunotherapies have revolutionized cancer treatment, but the non-responsiveness of most cancers to ICB-based monotherapy remains a significant problem. A major reason for the non-responsiveness of these so-called ‘cold’ tumors is that they lack…